Setmelanotide
RM-493-019
Phase 2 small_molecule completed
Quick answer
Setmelanotide for Hypertriglyceridemia is a Phase 2 program (small_molecule) at Rhythm Pharmaceuticals Netherlands B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Rhythm Pharmaceuticals Netherlands B.V.
- Indication
- Hypertriglyceridemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed